IMPACT OF CONCOMITANT THIOPURINE ON THE EFFICACY AND SAFETY OF FILGOTINIB TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: POST HOC ANALYSIS OF THE PHASE 2B/3 SELECTION STUDY

Kenji Watanabe  ¹     Laurent Peyrin-Biroulet  ²     Silvio Danese  ³     Kahaku Emoto  ⁴     Yasushi Fujitani  ⁴     Franck-Olivier Le-Brun  ⁵     Alessandra Oortwijn  ⁶     Tomohiro Ueno  ⁶     James O. Lindsay  ⁷     Gerhard Rogler  ⁸     Toshifumi Hibi  ^9    
1 Center for Inflammatory Bowel Disease, Division of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan
² University Hospital of Nancy, University of Lorraine, Nancy, France
³ IBD Center, Humanitas Research Hospital, Milan, Italy
⁴ Gilead Sciences K.K., Tokyo, Japan
⁵ Galapagos GmbH, Basel, Switzerland
⁶ Galapagos NV, Leiden, Netherlands
⁷ Centre for Immunobiology, Blizard Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom
⁸ University Hospital of Zurich, University of Zurich, Zurich, Switzerland
⁹ Center for Advanced IBD Research and Treatment, Kitasato Institute Hospital, Kitasato University, Tokyo, Japan

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)